Bio-View Ltd (TLV:BIOV)
Israel · Delayed Price · Currency is ILS · Price in ILA 85.70
0.00 (0.00%)
Aug 13, 2026, 5:24 PM IDT
Bio-View Market Cap
Bio-View has a market cap or net worth of 11.48 million as of August 13, 2026. Its market cap has decreased by -63.06% in one year.
Market Cap
11.48M
Enterprise Value
7.06M
Revenue
19.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.70
ChartMarket Cap Chart
Since April 3, 2006, Bio-View's market cap has decreased from 59.79M to 11.48M, a decrease of -80.79%. That is a compound annual growth rate of -7.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 11.48M | -48.68% |
| Dec 31, 2025 | 22.38M | -37.30% |
| Dec 31, 2024 | 35.69M | -21.62% |
| Dec 31, 2023 | 45.53M | -10.12% |
| Dec 29, 2022 | 50.66M | 13.09% |
| Dec 30, 2021 | 44.79M | -20.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 126.32B |
| Danel (Adir Yeoshua) | 2.56B |
| Amal Holdings A.D. | 2.33B |
| BrainsWay | 1.82B |
| Can-Fite BioPharma | 21.47M |
| XTL Biopharmaceuticals | 20.64M |
| Erika Carmel-Tech | 20.25M |
| Purple Biotech | 18.65M |